c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies
c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies
复制标题
DOI:
10.1038/s41590-019-0423-0
复制
发表时间:
2019-08-01
影响因子:
30.5
通讯作者:
Humbles, Alison A.
中科院分区:
文献类型:
--
作者:
Bernink, Jochem H.;Ohne, Yoichiro;Humbles, Alison A.
Here we identify a group 2 innate lymphoid cell (ILC2) subpopulation that can convert into interleukin-17 (IL-17)-producing NKp44(-) ILC3-like cells. c-Kit and CCR6 define this ILC2 subpopulation that exhibits ILC3 features, including ROR gamma t, enabling the conversion into IL-17-producing cells in response to IL-1 beta and IL-23. We also report a role for transforming growth factor-beta in promoting the conversion of c-Kit-ILC2s into ROR gamma t-expressing cells by inducing the upregulation of IL23R, CCR6 and KIT messenger RNA in these cells. This switch was dependent on ROR gamma t and the downregulation of GATA-3. IL-4 was able to reverse this event, supporting a role for this cytokine in maintaining ILC2 identity. Notably, this plasticity has physiological relevance because a subset of ROR gamma t(+) ILC2s express the skin-homing receptor CCR10, and the frequencies of IL-17-producing ILC3s are increased at the expense of ILC2s within the lesional skin of patients with psoriasis.